Literature DB >> 15075726

Splanchnic metabolism in acute liver failure and sepsis.

Otto Clemmesen1, Peter Ott, Fin Stolze Larsen.   

Abstract

PURPOSE OF REVIEW: A number of papers have suggested that the splanchnic circulation and oxidative metabolism are compromised in critical illness. This review discusses this hypothesis and outlines the recent advances in the understanding of splanchnic metabolism with special focus on acute liver failure and hyperdynamic sepsis. RECENT
FINDINGS: Splanchnic blood flow, oxygen delivery, and consumption are increased in both acute liver failure and sepsis. The capability of the liver to extract oxygen, even under extreme conditions, renders the liver less prone to hypoxia. A common feature of acute liver failure and sepsis is a hypermetabolic state with enhanced glycolysis and production of lactate and pyruvate. Human studies on other features of intermediary metabolism are sparse, but there are indications that several intermediary processes are severely compromised in patients with acute liver failure, whereas these processes are maintained in sepsis.
SUMMARY: There is increasing evidence that both acute liver failure and sepsis are accompanied by a hypermetabolic state in the hepatosplanchnic area, characterized by enhanced glycolysis and hyperlactatemia. This should not be rigorously interpreted as an indication of hypoxia. In fact, clinically important splanchnic hypoxia may be a relatively uncommon phenomenon in such patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075726     DOI: 10.1097/00075198-200404000-00012

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  7 in total

Review 1.  Cerebral effects of ammonia in liver disease: current hypotheses.

Authors:  Peter Ott; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2014-02-04       Impact factor: 3.584

2.  Two-hour lactate clearance predicts negative outcome in patients with cardiorespiratory insufficiency.

Authors:  Sean Scott; Vittorio Antonaglia; Giovanna Guiotto; Fiorella Paladino; Fernando Schiraldi
Journal:  Crit Care Res Pract       Date:  2010-06-28

Review 3.  Relative adrenal insufficiency in cirrhotic patients.

Authors:  Sotirios N Anastasiadis; Olga I Giouleme; Georgios S Germanidis; Themistoklis G Vasiliadis
Journal:  Clin Med Insights Gastroenterol       Date:  2015-03-02

4.  The Effect of Adrenal Replacement Therapy on Rates of Fungal Colonization and Mortality in Critically Ill Patients Awaiting Liver Transplantation.

Authors:  Stephanie G Yi; Archana R Sadhu; Stephen L Jones; Krista Turner; Howard Monsour; Kevin Donahue; Xuefeng Xia; A Osama Gaber; R Mark Ghobrial; Sherilyn Gordon Burroughs
Journal:  J Clin Transl Hepatol       Date:  2013-09-15

5.  Clinical characteristics and prevalence of adrenal insufficiency in hemodynamically stable patients with cirrhosis.

Authors:  Sang Hoon Park; Min Sun Joo; Byoung Hoon Kim; Ha Na Yoo; Sung Eun Kim; Jin Bae Kim; Myoung Kuk Jang; Dong Jun Kim; Myung Seok Lee
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

6.  Glycogenic hepatopathy in children with poorly controlled type 1 diabetes mellitus.

Authors:  Nor Azizah Abu; Chooi Bee Lim; Noor Shafina Mohd Nor
Journal:  Clin Pediatr Endocrinol       Date:  2021-04-03

7.  Glycogenic Hepatopathy.

Authors:  Bashar Sharma; Marsha Antoine; Mili Shah; Rochelle Nagales Nagamos; Savio John
Journal:  ACG Case Rep J       Date:  2019-07-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.